Alpine Partners VI »

Regulus Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $105k 59k 1.79

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics